Chairman of the Board, elected 2019. (b. 1950)
Education and experience: Arne Ferstad, bachelor’s degree in Market Economy, CEDEP/INSEAD, has a broad range of experience in the biotech and pharmaceutical industries, including business development and international marketing. He is the CEO and Director of Ankor Consultants Ltd. He was previously in charge of Baxter Healthcare’s business in the Nordic and Benelux countries, President of EMEA Baxter Renal Division, head of Baxter’s bioscience business in Asia and held several senior positions in Baxter R&D. Arne was also General Manager and Vice President at Pharmacia Corporation.
Current assignments: CEO and Chairman of the Board of Ankor Consultants Ltd. Board member of Peptonic Medical AB (publ) and Clinical Laserthermia Systems AB (publ). Chairman of the Board of FluoGuide AS. Chairman of the Board of Combigene AB.
Previous assignments: Board member of Cline Scientific AB and Neurovive Pharmaceutical AB (publ). Chairman of the Board of AroCell AB, Medfield Diagnostics AB (publ) and Aggancio Research AB.
Owner and active in the following companies: Ankor Consultants Ltd.
Board member, elected 2016. (b. 1966)
Education and experience: Lars Thunberg is a co-founder of CombiGene and was also its Chairman of the Board from August 2013 to October 2014. He has an M.Sc. in Business Administration and Economics from Stockholm University and Lund University.
Current assignments: Board Member of CombiGene AB and Board Member of M & L Industriförvaltning.
Previous assignments: Chairman of the Board of Panion Animal Health AB (2016-2019). Board Member of Högskolan Kristianstad Holding AB, Högskolan Kristianstad Uppdrag AB and Estrids Fastighet Hässleholm AB. Chairman of the Board of aXimed AB (publ), aXichem AB (publ), Camito Sweden AB, VA Automation i Hässleholm AB, SwePart verktyg i Tyringe AB, VA International AB, Ningbo Modern Tool and MV HK LTD. Board Member of VA Components i Hässleholm AB, VA Tooling AB, VA Engineering i Hässleholm AB, Hardmesch AB, VA Personal AB.
Owner and active in the following companies: M & L Industriförvaltning.
Board member, elected 2019. (b. 1949)
Education and experience: Jan Nilsson has an MA from the University of Gothenburg and an MBA from Uppsala University. Jan is currently the CEO of CombiGene AB, appointed on 1 October 2016. He has long-standing experience from large pharmaceutical companies and biotech firms. He has also been active in several different areas in the pharmaceutical industry such as pharmaceuticals development and the launch, sales and marketing of established international brands. He also has a solid management background, having served as CEO of both private and public-sector companies.
Current assignments: Board member of CanImGuide Therapeutics AB, and Urbicum Ledningskonsult AB.
Previous assignments: CEO of NeuroVive Pharmaceutical AB.
Owner and active in the following companies: Urbicum Ledningskonsult AB.